First-quarter 2017 financial update
Inventiva to Present at the H.C. Wainwright NASH Investor Conference St. Regis Hotel, New-York, April 3d 2017
Acceleration of the clinical development activities and consolidation of the financial position in 2016
Announces the partial exercise of the over-allotment option
Inventiva raises €48 million in a successful initial public offering
Announces initiation of Phase IIb Clinical Trial of IVA337 in NASH
No front page content has been created yet.